SUBSTITUIERTE XANTHINDERIVATE

Patent europeic · EP2265612 · En vigur

Inscripziun en il register

Numer da publicaziun
EP2265612
Numer da la dumonda
EP09715566
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-02-2009
Publitgà
29-12-2010
Concedì
05-04-2017
La protecziun finescha il pli tard
26-02-2029
Proxima taxa annuala scadenta
28-02-2027
Classas IPC
C07D 473/06 (2006.01)
A61K 31/522 (2006.01)
A61P 1/16 (2006.01)
A61P 13/12 (2006.01)
Prioritad
US 67736 P 29.02.2008
US 134568 P 11.07.2008
US 198715 P 07.11.2008
Dumonda PCT
PCT/US2009/001294 27.02.2009
Publicaziun PCT
WO2009/108375 03.09.2009
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-03-2026

    Midada

    Published in Swissreg on 01.03.2026

  2. 04-03-2025

    Midada

    Published in Swissreg on 04.03.2025

  3. 01-03-2024

    Midada

    Published in Swissreg on 01.03.2024

  4. 06-03-2023

    Midada

    Published in Swissreg on 06.03.2023

  5. 05-04-2017

    Concedì

    Published in Swissreg on 05.04.2017

Partidas

Possessur

Concert Pharmaceuticals, Inc.

CONCERT PHARMACEUTICALS, INC.

99 Hayden Avenue, Suite 500, Lexington, MA 02421, US

Inventur

TUNG, Roger, D.

Lexington MA 02420, US

LIU, Julie, F.

Lexington MA 02420, US

HARBESON, Scott, L.

Cambridge MA 02140, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.